Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Mar 02, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-030900.pdf
0001104659-21-030900.rtf
0001104659-21-030900.xls
Feb 25, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-027845.pdf
0001104659-21-027845.rtf
0001104659-21-027845.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 25, 2021 10-K

Annual report which provides a comprehensive overview of the company for the past year

View HTML
0001558370-21-001804.pdf
0001558370-21-001804.rtf
0001558370-21-001804.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 25, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-028419.pdf
0001104659-21-028419.rtf
0001104659-21-028419.xls
Feb 23, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-026702.pdf
0001104659-21-026702.rtf
0001104659-21-026702.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 22, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-026191.pdf
0001104659-21-026191.rtf
0001104659-21-026191.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 17, 2021 3

Initial filing by director officer or owner of more than ten percent.

View HTML
0001104659-21-024923.pdf
0001104659-21-024923.rtf
0001104659-21-024923.xls
Feb 17, 2021 3

Initial filing by director officer or owner of more than ten percent.

View HTML
0001104659-21-024924.pdf
0001104659-21-024924.rtf
0001104659-21-024924.xls
Feb 17, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-024922.pdf
0001104659-21-024922.rtf
0001104659-21-024922.xls
Feb 17, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-024925.pdf
0001104659-21-024925.rtf
0001104659-21-024925.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.